CYTOKINETICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cytokinetics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Cytokinetics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$161M, a 24% decline year-over-year.
  • Cytokinetics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$576M, a 9.43% decline year-over-year.
  • Cytokinetics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$526M, a 35.3% decline from 2022.
  • Cytokinetics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$389M, a 80.6% decline from 2021.
  • Cytokinetics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$215M, a 69.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$576M -$161M -$31.1M -24% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$545M -$143M -$14.7M -11.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$531M -$136M -$4.35M -3.32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$526M -$137M +$484K +0.35% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$527M -$129M +$12.9M +9.06% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$540M -$129M -$109M -549% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$431M -$131M -$41.8M -46.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$389M -$137M -$107M -349% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$282M -$142M -$66.2M -87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$216M -$19.8M +$41.7M +67.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$258M -$89.4M -$42.3M -89.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$215M -$30.6M +$13.4M +30.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$229M -$76.1M -$72.9M -2296% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$156M -$61.6M -$20.8M -50.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$135M -$47.1M -$7.7M -19.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$127M -$43.9M -$13.3M -43.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$114M -$3.18M +$26.4M +89.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$140M -$40.8M -$8.67M -27% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$132M -$39.4M -$10M -34.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$122M -$30.6M -$4.17M -15.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$118M -$29.6M -$7.56M -34.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$110M -$32.1M -$4.59M -16.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 -$105M -$29.4M +$915K +3.02% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 -$106M -$26.5M +$14M +34.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$120M -$22M +$10.3M +32% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 -$131M -$27.5M +$1.56M +5.36% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-01
Q1 2018 -$132M -$30.3M -$4.41M -17.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-01
Q4 2017 -$128M -$40.5M -$47.6M -666% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-05
Q3 2017 -$80.1M -$32.4M -$65.7M -197% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$14.4M -$29.1M -$17.5M -150% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $3.04M -$25.9M -$13.4M -108% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $16.5M $7.16M +$16.4M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 $67K $33.4M +$42.2M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-05
Q2 2016 -$42.1M -$11.6M -$1.06M -10% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-05
Q1 2016 -$41.1M -$12.5M -$3.58M -40.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-05
Q4 2015 -$37.5M -$9.23M -$17.7M -209% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$19.8M -$8.85M -$2.88M -48.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$17M -$10.6M -$2.18M -26% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$14.8M -$8.87M -$128K -1.46% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$14.6M $8.44M +$1.91M +29.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-03
Q3 2014 -$16.6M -$5.97M +$6.62M +52.6% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-03
Q2 2014 -$23.2M -$8.37M +$6.67M +44.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-03
Q1 2014 -$29.8M -$8.74M +$3.88M +30.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-03
Q4 2013 -$33.7M $6.53M +$18M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-06
Q3 2013 -$51.7M -$12.6M -$2.54M -25.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-06
Q2 2013 -$49.2M -$15M -$6.1M -68.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-06
Q1 2013 -$43.1M -$12.6M -$2.69M -27.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-06
Q4 2012 -$40.4M -$11.5M +$422K +3.55% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$40.8M -$10M +$595K +5.59% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-07
Q2 2012 -$41.4M -$8.94M +$4.69M +34.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-07
Q1 2012 -$46.1M -$9.93M +$1.78M +15.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-07
Q4 2011 -$47.9M -$11.9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$10.6M +$1.7M +13.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$13.6M -$488K -3.71% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$11.7M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$12.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$13.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.